Cerenome names director Ron Andrews chief business officer
CNSY•Cerenome appointed Ron Andrews to the newly created chief business officer role, where he will lead business development and commercial strategy.
1. New leadership role
Andrews will focus on expanding adoption of CNSide diagnostics and developing strategic partnerships. He previously served as CEO of Clarient and Oncocyte and has more than 35 years of diagnostics industry leadership experience.
